We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

1 hedge funds and large institutions have $0 invested in Repros Therapeutics Inc. in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% less funds holding

Funds holding: 30 → 1 (-29)

100% less capital invested

Capital invested by funds: $3.33M → $0 (-$3.33M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 29

Holders
1
Holders Change
-29
Holders Change %
-96.67%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$773K
2
Renaissance Technologies
Renaissance Technologies
New York
-$525K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$486K
4
BlackRock
BlackRock
New York
-$454K
5
KAM
Kassirer Asset Management
Ontario, Canada
-$435K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
– -$773K -1,171,544 Closed
Renaissance Technologies
2
Renaissance Technologies
New York
– -$525K -794,913 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$486K -735,447 Closed
BlackRock
4
BlackRock
New York
– -$454K -687,032 Closed
KAM
5
Kassirer Asset Management
Ontario, Canada
– -$435K -659,230 Closed
AIA
6
Allegis Investment Advisors
Idaho
– -$260K -394,206 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
– -$86K -131,112 Closed
California Public Employees Retirement System
8
California Public Employees Retirement System
California
– -$78K -118,000 Closed
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
– -$61K -91,976 Closed
Northern Trust
10
Northern Trust
Illinois
– -$56K -83,753 Closed
Bank of New York Mellon
11
Bank of New York Mellon
New York
– -$24K -36,983 Closed
Bank of America
12
Bank of America
North Carolina
– -$16K -24,992 Closed
Group One Trading
13
Group One Trading
Illinois
– -$16K -24,735 Closed
UBS Group
14
UBS Group
Switzerland
– -$16K -23,781 Closed
Citadel Advisors
15
Citadel Advisors
Florida
– -$10K -15,518 Closed
State Street
16
State Street
Massachusetts
– -$9K -13,551 Closed
Goldman Sachs
17
Goldman Sachs
New York
– -$7K -11,147 Closed
MWAC
18
Mariner Wealth Advisors (Cincinnati)
Ohio
– -$7K -11,000 Closed
Wells Fargo
19
Wells Fargo
California
– -$4K -6,000 Closed
FPF
20
FNY Partners Fund
New York
– -$1K -2,794 Closed
BFEC
21
Benjamin F. Edwards & Company
Missouri
– -$2K -2,700 Closed
BWP
22
Baldwin Wealth Partners
Massachusetts
– -$1K -1,750 Closed
Bank of Montreal
23
Bank of Montreal
Ontario, Canada
– -$1K -1,000 Closed

RPRX Hedge Fund Activity: Q1 2018 in Review

1 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q1 2018, worth a combined $0 — down 100% from $3.33M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of RPRX and 0 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $773K sold.

  • 1 institutional investor held Repros Therapeutics Inc. (RPRX) as of Q1 2018, down from 30 in Q4 2017.
  • Funds reported $0 of Repros Therapeutics Inc. stock for Q1 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Repros Therapeutics Inc. positions in Q1 2018 and 29 closed out, a net change of -29 holders.
  • The largest Repros Therapeutics Inc. seller in Q1 2018 was Fidelity Investments, an estimated $773K sold.

Based on aggregated 13F filings for Q1 2018.